U.S. markets open in 6 hours 15 minutes
  • S&P Futures

    3,642.25
    +9.50 (+0.26%)
     
  • Dow Futures

    30,052.00
    +54.00 (+0.18%)
     
  • Nasdaq Futures

    12,123.25
    +47.25 (+0.39%)
     
  • Russell 2000 Futures

    1,858.10
    +6.60 (+0.36%)
     
  • Crude Oil

    45.44
    +0.53 (+1.18%)
     
  • Gold

    1,809.40
    +4.80 (+0.27%)
     
  • Silver

    23.36
    +0.06 (+0.26%)
     
  • EUR/USD

    1.1930
    +0.0034 (+0.29%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3378
    +0.0020 (+0.15%)
     
  • USD/JPY

    104.3680
    -0.1120 (-0.11%)
     
  • BTC-USD

    19,035.78
    +181.79 (+0.96%)
     
  • CMC Crypto 200

    377.58
    +7.83 (+2.12%)
     
  • FTSE 100

    6,454.21
    +22.04 (+0.34%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Freeport's (FCX) Earnings and Sales Top Estimates in Q3

Zacks Equity Research
·3 min read

Freeport-McMoRan Inc. FCX reported net income (attributable to common stock) of $329 million or 22 cents per share in third-quarter 2020 against a net loss of $207 million or 15 cents in the year-ago quarter.

Barring one-time items, adjusted earnings per share came in at 29 cents that surpassed the Zacks Consensus Estimate of 24 cents.

Revenues rose 16.4% year over year to $3,851 million. The figure also beat the Zacks Consensus Estimate of $3,757.6 million.

FreeportMcMoRan Inc. Price, Consensus and EPS Surprise

 

FreeportMcMoRan Inc. Price, Consensus and EPS Surprise
FreeportMcMoRan Inc. Price, Consensus and EPS Surprise

FreeportMcMoRan Inc. price-consensus-eps-surprise-chart | FreeportMcMoRan Inc. Quote

Operational Update

Copper production fell 2.3% year over year to 844 million pounds in the third quarter.

Consolidated sales from mines rose 6.7% year over year to 848 million pounds of copper. The company produced 237,000 ounces of gold and 19 million pounds of molybdenum during the quarter.

Consolidated average unit net cash costs per pound of copper were $1.32, down 17% year over year.

Average realized price for copper was $3.01 per pound, up 14.9% year over year. Average realized price per ounce for gold increased 27.9% year over year to $1,902. Average realized price per pound for molybdenum was $9.23, down 28.4% year over year.

Financial Position

Cash and cash equivalents at the end of the third quarter were $2,403 million, up 6.9% year over year. The company’s long-term debt was $9,983 million.

Cash flows provided by operations were $1,690 million for the nine months ended Sep 30, up 28.8% year over year.

Guidance

For 2020, Freeport now anticipates consolidated sales volumes to be 3.18 billion pounds of copper compared with 3.15 billion pounds expected earlier.

The company continues to expect gold sales volumes of 800,000 ounces for 2020, unchanged from previous forecast. It now expects sales of 80 million pounds of molybdenum compared with 77 million pounds expected earlier.

For the fourth quarter, Freeport expects sales volumes to be 840 million pounds of copper, 270,000 ounces of gold and 21 million pounds of molybdenum.

Price Performance

Freeport’s shares have gained 74.9% in the past year compared with the industry’s 40.4% rise.

Zacks Rank & Key Picks

Freeport currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Eldorado Gold Corporation EGO, Agnico Eagle Mines Limited AEM and Barrick Gold Corporation GOLD, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Eldorado Gold has an expected earnings growth rate of 2,400% for 2020. The company’s shares have surged 77.3% in the past year.

Agnico Eagle has an expected earnings growth rate of 104.1% for 2020. Its shares have returned 54% in the past year.

Barrick has an expected earnings growth rate of 148% for 2020. The company’s shares have gained 64.9% in the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
FreeportMcMoRan Inc. (FCX) : Free Stock Analysis Report
 
Barrick Gold Corporation (GOLD) : Free Stock Analysis Report
 
Agnico Eagle Mines Limited (AEM) : Free Stock Analysis Report
 
Eldorado Gold Corporation (EGO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.